IRX2 and neoplasm: All this evidence adds up in favor of the hypothesis that SPP1/osteopontin expression may be controlled by IRX2, and that its derepression in senescent fibroblast aids in SIPS-dependent stromal activation that, in turn, stimulate the growth of tumor cells.